Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

por Takahashi, Ken, Seto, Yosuke, Okada, Koutaroh, Uematsu, Shinya, Uchibori, Ken, Tsukahara, Mika, Oh‐hara, Tomoko, Fujita, Naoya, Yanagitani, Noriko, Nishio, Makoto, Okubo, Kenichi, Katayama, Ryohei
Publicado 2020

Interstitial Lung Disease as an Initial Manifestation of Giant Cell Arteritis

por Konishi, Chisato, Nakagawa, Kazuhiko, Nakai, Erika, Nishi, Kenta, Ishikawa, Ryoichi, Uematsu, Shinya, Nakao, Satoshi, Taki, Masato, Morita, Kyohei, Hee, Hwang Moon, Yoshimura, Chie, Wakayama, Toshiaki, Nishizaka, Yasuo
Publicado 2017

Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand...

por Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Uchibori, Ken, Yanagitani, Noriko, Horiike, Atsushi, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Publicado 2020

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

por Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Ariyasu, Ryo, Uchibori, Ken, Yanagitani, Noriko, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto
Publicado 2020

Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study

por Kawachi, Hayato, Tamiya, Motohiro, Taniguchi, Yoshihiko, Yokoyama, Toshihide, Yokoe, Shinya, Oya, Yuko, Imaji, Mihoko, Okabe, Fukuko, Kanazu, Masaki, Sakata, Yoshihiko, Uematsu, Shinya, Tanaka, Satoshi, Arai, Daisuke, Saito, Go, Kobe, Hiroshi, Miyauchi, Eisaku, Okada, Asuka, Hara, Satoshi, Kumagai, Toru
Publicado 2022

Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study...

por Uematsu, Shinya, Kitazono, Satoru, Tanaka, Hisashi, Saito, Ryota, Kawashima, Yosuke, Ohyanagi, Fumiyoshi, Tozuka, Takehiro, Ryosuke, Tsugitomi, Sakatani, Toshio, Horiike, Atsushi, Yoshizawa, Takahiro, Saiki, Masafumi, Tambo, Yuichi, Koyama, Junji, Kanazu, Masaki, Kudo, Keita, Tsuchiya‐Kawano, Yuko, Yanagitani, Noriko, Nishio, Makoto
Publicado 2022